Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06831149Phase 2Recruiting
Phase 2, open-label, single-arm trial. Primary endpoint: Incidence of Pharyngocutaneous Fistula at 1 month. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06831149.